PhM4.0 China Pharmaceutical Manufacturing 4.0 Summit

The integration and development of intelligent manufacturing and pharmaceutical industry can greatly promote the intelligence, informatization and traceability of pharmaceutical manufacturing The application of the overall solution of intelligent pharmaceutical engineering will greatly improve the production efficiency, production flexibility and resource allocation while ensuring the high compliance of pharmaceutical production and GMP, so as to achieve energy conservation and consumption reduction As an important part of the 10th China (Taizhou) International Pharmaceutical Expo, phm4.0 China pharmaceutical manufacturing 4.0 summit is scheduled to be held at the conference center of Taizhou pharmaceutical city from September 18 to 19, 2019 The summit will invite a number of experts, such as the government leading the development of intelligent manufacturing, the pharmaceutical enterprises leading the practice of intelligent production and the suppliers of intelligent production technology and equipment, to interpret the policy of pharmaceutical manufacturing industry in the context of industry 4.0, analyze the new situation of pharmaceutical "intelligent" manufacturing, discuss the technical challenges and practical experience of Intelligent Manufacturing in the pharmaceutical industry, and work together to Intelligent manufacturing in the pharmaceutical industry provides the latest solutions Sponsor Taizhou · China Pharmaceutical city BMAP Shanghai Shangtu Information Consulting Co., Ltd supporting unit China Chemical Pharmaceutical Industry Association summit agenda medical Expo opening ceremony pharmaceutical manufacturing policy and trend "opening speech" against the background of industry 4.0 -- pan Guangcheng, executive chairman of China Chemical Pharmaceutical Industry Association "The latest standards of supervision and verification for promoting the integration of" two modernizations "in the pharmaceutical industry" -- Gao Tianbing, deputy director of the drug regulatory department of the State Drug Administration, "the current situation of the preparation of China pharmaceutical industry intelligent manufacturing guide and relevant policy reform" -- experts from the pharmaceutical department of the consumer goods industry department of the Ministry of industry and information technology "compliance requirements for the implementation of information production and quality management" --"About the latest development trend of pharmaceutical manufacturing 4.0" of Jiangsu Provincial Drug Administration -- Zhang natural, vice president of China Chemical Pharmaceutical Industry Association, technology and challenge of "intelligent factory" transformation of pharmaceutical manufacturing, intelligent biopharmaceutical factory -- Li Shude, CEO of Peking University Weiming (Hefei) biopharmaceutical Co., Ltd exploration and Practice of Intelligent Manufacturing in the whole pharmaceutical industry chain --Liu Xuesong, executive vice president of Institute of modern Chinese medicine, Zhejiang University, and the leap and transformation of drugs from automation to intelligent production -- Zhang Ping, head of Sanofi's China Industrial Affairs, chairman of ISPE's China production and Engineering Committee (TBD) progress of continuous production of drugs --Ye Weiping, continuous production expert, practical experience of intelligent manufacturing pilot demonstration project in pharmaceutical industry of CEO of Guangdong Raffles Pharmaceutical Technology Co., Ltd -- Zhang Shunnan, deputy general manager (TBD) of Tianshili Pharmaceutical Group Co., Ltd application of MES system in domestic pharmaceutical workshop -- jingruifeng, person in charge of MES system of Xi'an YANGSEN Pharmaceutical Co., Ltd To explore the life cycle management of products and intelligent pharmaceutical engineering equipment -- a round table discussion of Guo Hongxing and Luo Xin'an ruowita (Chengdu) Pharmaceutical Co., Ltd Deputy General Manager: To explore the rational mode and key elements of intelligent manufacturing of medicine; to establish modern quality management system; to establish automation and digital production system; to apply the new generation of information technology Moderator: Zhang Jinwei, dandelion founder Wang Yanzhong, former CFDA Visiting Professor Ding Kaiyun, director of IT Department of Zhejiang Pharmaceutical Co., Ltd., it director of Zhejiang innovation biology Co., Ltd influence of application of automatic control technology on drug quality Qu Yunping, director of Quality Assurance Department of Shenwei Pharmaceutical Group Co., Ltd Ø pharmaceutical enterprises: Production Technology Department, production management department, quality control department, quality management department, equipment department, engineering department, technology department, supply chain department, information department, data management department and senior management personnel Ø CMO senior management personnel Ø pharmaceutical industry Intelligent Manufacturing Technology Research Institute and company personnel free seats, first come first get! This summit provides limited free participation vouchers (only for pharmaceutical enterprise personnel), which can be participated free of charge after the approval of the Organizing Committee; if you are a pharmaceutical technical service and equipment provider and other people concerned about the pharmaceutical industry, now you can enjoy a 10% discount for three people in the same industry by signing up! Limited sponsorship seats! Become a sponsor of the summit, and provide you with a full range of pharmaceutical intelligent manufacturing solutions in various forms such as keynote speech, product display, cooperation invitation, etc! To register now, please scan the QR code below or copy the official website directly For details of the conference and sponsorship, please consult the organizing committee to explore pharmaceutical manufacturing 4.0! This article is reprinted by yaozhi.com The copyright belongs to the original author The purpose of reprint is to transmit more information, which does not represent the view of this platform If the content of the work, copyright and other issues are involved, please contact our website message, we will delete the content in the first time.